Explore the revolutionary pipeline for personalized ovarian cancer treatment through drug sensitivity testing and precision medicine approaches.
Discover how combined inhibition of mTOR and HSP90 overcomes cisplatin resistance in ovarian cancer through innovative research and clinical potential.
Exploring how the extracellular matrix influences ovarian cancer progression and immune response through the tumor microenvironment.
Exploring how spatial transcriptomics is revolutionizing our understanding of high-grade serous ovarian cancer by mapping gene activity within intact tissue sections.